Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in SKYE — Skye Bioscience, Inc.

CIK 1273087 NEW YORK, NY
Back to SKYE Full portfolio

Position in SKYE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,204
-$2,632 QoQ
Shares Held
24,816
-23.1% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 42 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SKYE Over Time

Shares Held

Position Value (USD)

Derivatives in SKYE

reported options exposure · as of Sep 30, 2025
CallValue
$20,878
CallShares
5,312
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. SKYE ranks #318 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3
1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in SKYE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,204 198,524
2026-03-31 $19,836 258,200
2025-12-31 $35,655 380,478
2025-09-30 $197,666 402,375
2025-09-30 $20,878 42,500
2025-06-30 $245,955 470,729
2024-09-30 $192,756 394,386